[HN Gopher] LSD, Psilocybin, and DMT in Depression Treatment: A ...
___________________________________________________________________
LSD, Psilocybin, and DMT in Depression Treatment: A Systematic
Review
Author : beefman
Score : 11 points
Date : 2021-09-14 17:47 UTC (5 hours ago)
(HTM) web link (www.mdpi.com)
(TXT) w3m dump (www.mdpi.com)
| peanut_worm wrote:
| > Psilocybin is an agonist of 5HT2a serotonin receptors; however,
| unlike LSD, it has no effect on dopamine receptors
|
| Thats surprising considering how similar their effects are.
| beefman wrote:
| Look at the receptor binding affinities in tables 1 and 3 (note
| that psilocin is the active metabolite of psilocybin, and that
| lower numbers indicate stronger binding)
|
| https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110631/
|
| LSD has about 8 times the affinity for 5-HT2A as D3, vs 25
| times for psilocin. This doesn't tell us anything about how
| they act on the receptors, or the affinities of the endogenous
| ligands they're competing with, but I think it's unlikely the
| dopaminergic activity is significant for either drug.
|
| Edit: This does cite a paper from Nichols' lab[1] which claims
| LSD has a second phase of action after the serotonergic phase,
| where its dopaminergic activity dominates. This strikes me as
| plausible... I'd have to read it.
|
| [1] https://pubmed.ncbi.nlm.nih.gov/17618679/
| samename wrote:
| > 10 papers were included. Most of the selected studies showed
| significant correlation between psilocybin and DMT use and
| reduction in depression symptom intensity. By analyzing qualified
| studies, it can be concluded that psilocybin and DMT could be
| useful in depression treatment, but further observations are
| still required.
___________________________________________________________________
(page generated 2021-09-14 23:02 UTC)